CYTX - Cytori Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 519.14M
Enterprise Value 322.58M
Trailing P/E N/A
Forward P/E 1-1.39
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.99
Price/Book (mrq)1.42
Enterprise Value/Revenue 33.52
Enterprise Value/EBITDA 6-1.34

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-296.32%

Management Effectiveness

Return on Assets (ttm)-35.86%
Return on Equity (ttm)-189.16%

Income Statement

Revenue (ttm)6.41M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)-49.50%
Gross Profit (ttm)5.09M
EBITDA -16.85M
Net Income Avi to Common (ttm)-26.66M
Diluted EPS (ttm)-0.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.55M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)13.62M
Total Debt/Equity (mrq)104.80
Current Ratio (mrq)0.81
Book Value Per Share (mrq)0.22

Cash Flow Statement

Operating Cash Flow (ttm)-18.13M
Levered Free Cash Flow (ttm)-12M

Trading Information

Stock Price History

Beta 1.57
52-Week Change 3-80.93%
S&P500 52-Week Change 315.75%
52 Week High 32.08
52 Week Low 30.22
50-Day Moving Average 30.35
200-Day Moving Average 30.37

Share Statistics

Avg Vol (3 month) 31.65M
Avg Vol (10 day) 31.04M
Shares Outstanding 559.82M
Float 56.97M
% Held by Insiders 18.46%
% Held by Institutions 116.89%
Shares Short 33.23M
Short Ratio 34.76
Short % of Float 313.81%
Shares Short (prior month) 33.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/15
Last Split Date 3May 12, 2016